Accuray Incorporated (NASDAQ:ARAY) is set to announce first quarter earning results on Thursday 29th October 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, ARAY to report 1Q21 loss of $ 0.07 per share.
For the full year, analysts anticipate top line of $ 385.34 million, while looking forward to loss of $ 0.11 per share bottom line.
Stock Performance
Shares of Accuray Incorporated traded low $ -0.16 or -5.33 percent on Wednesday, reaching $ 2.84 with volume of 910.80 thousand shares. Accuray Incorporated has traded high as $ 2.97 and has cracked $ 2.82 on the downward trend
According to the previous trading day, closing price of $ 2.84, representing a 125.56 % increase from the 52 week low of $ 1.33 and a 35.9 % decrease over the 52 week high of $ 4.68.
The company has a market capital of $ 259.01 million and is part of the Healthcare sector and Medical Appliances & Equipment industry.
Conference Call
Accuray Incorporated will be hosting a conference call at 4:30 PM eastern time on 29th October 2020, to discuss its 1Q21 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.accuray.com
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally.
